Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma.

Suriano, Robert; Rajoria, Shilpi; George, Andrea L; Geliebter, Jan; Tiwari, Raj K; Wallack, Marc

Suriano, Robert; Rajoria, Shilpi; George, Andrea L; Geliebter, Jan; Tiwari, Raj K; Wallack, Marc.

Afiliación

Suriano R; Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595;
Rajoria S; Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595;
George AL; Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595;
Geliebter J; Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595;
Tiwari RK; Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595;
Wallack M; Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595; ; Department of Surgery, Metropolitan Hospital Center GNS, New York, NY 10029, USA.

Mol Clin Oncol ; 1(3): 466-472, 2013 May.

Article en En | MEDLINE | ID: mdl-24649193

Palabras clave

immunotherapy; melanoma; vaccine; vaccinia virus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Mol Clin Oncol Año: 2013 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google